ARCHIVES

FDA Official Outlines agency’s Views On Efficacy Requirement

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

House Bill Gives NCI $48 Mil. Less Than Clinton Requested

July 8, 1994

Science Policy: NCAB Opposes Law Making Data Available Under FOIA; Individuals Encouraged To Send comments To OMB

March 19, 1999

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

Dugan Head ACCC, Yarbro President Elects; Amos Honored

March 18, 1983